MedTrace Logo

Roles of Some Non-classic Biomarkers in Pediatric Pneumonia

NCT05701605 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 120

Last updated 2023-01-27

No results posted yet for this study

Summary

The current work aims to:

1. Measure the levels of Neutrophil CD64 Receptor, Monocyte Human Leukocyte Antigen-DR (mHLA-DR), and Triggering Receptor Expressed on Myeloid Cells 1 (TREM-1) in children suffering from pneumonia.
2. Compare these levels to their levels in healthy control children.
3. Analyze the cut-off point, sensitivity, specificity, and area under the ROC curve of these biomarkers to test their abilities to early differentiate children with pneumonia from healthy control children.
4. Conclude or reject their possible use as diagnostic and/or prognostic markers in pediatric pneumonia.

Conditions

  • Pneumonia in Children

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Principal Investigators

  • El-Sayed Khalil, Prof · Assiut University

  • Yasser Farouk, Assist prof · Assiut University

  • Khalid Mohany, Assist prof · Assiut University

Eligibility

Min Age
1 Month
Max Age
5 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-07-01
Primary Completion
2024-01-01
Completion
2024-06-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05701605 on ClinicalTrials.gov